Merck’s Keytruda holds on to the top spot while AbbVie’s Humira—once the world’s top-selling drug—continues to cede its ...

In people with a life-threatening clot and no identification of what caused it, or if something caused it that can't be fixed ...

Although new U.S. tariffs on Canada, Mexico, and China are putting pressure on markets, investors are shifting toward ...

The blood thinner Eliquis was Bristol Myers Squibb’s highest revenue-generating medication last year. It was also one of the 10 drugs that were subject to Medicare price negotiations under the ...

For this understudied population, the findings may offer some reassurance as apixaban is already the most prescribed OAC in ...

Summary Apixaban is an oral ... regimen in clinical trials without the need for anticoagulation monitoring or dosage adjustment. Apixaban has multiple elimination pathways, and its ...

A. Eliquis (apixaban) is a lifesaving anticoagulant that reduces the risk of blood clots that could cause a stroke. The price in the U.S. is more than $600 for a month’s supply. That’s with a coupon ...

Welcome to Medicare Part D, where your prescription drugs come with co-pays and co-insurance. If you thought co-pays and ...